Interpretation and Management of Low TSAT with High Ferritin

Pathophysiology and Differential Diagnosis

Low TSAT (<20%) with elevated ferritin (100-700 ng/mL or higher) represents a common clinical conundrum that can be caused by two main conditions, according to the American Journal of Kidney Diseases: functional iron deficiency and inflammatory iron block 1, 3
Functional iron deficiency occurs when iron stores are adequate but iron cannot be effectively mobilized for erythropoiesis, often seen during erythropoietin therapy, as noted by the American Journal of Kidney Diseases 2, 4
Inflammatory iron block results from inflammation-driven hepcidin elevation, which restricts iron availability despite adequate or high iron stores, as reported by the American Journal of Hematology 5, 6

Traditional thresholds for absolute iron deficiency (ferritin <100 ng/mL and TSAT <20%) do not apply in inflammatory states, according to the American Journal of Kidney Diseases 2, 4
For patients with chronic diseases and inflammation, TSAT <20% with ferritin >300 ng/mL is likely functional iron deficiency or inflammatory block, as suggested by the American Journal of Hematology 5
Soluble transferrin receptor (sTfR) is elevated in true iron deficiency but not in functional iron deficiency; less affected by inflammation, as noted by Blood Reviews 8

For suspected functional iron deficiency, a trial of intravenous (IV) iron (50-125 mg weekly for up to 8-10 doses) is recommended by the American Journal of Kidney Diseases 1, 3
For suspected inflammatory iron block, addressing the underlying inflammatory condition before continuing iron therapy is crucial, as advised by the American Journal of Kidney Diseases 3
For patients on erythropoietin therapy, maintaining TSAT >20% and ferritin >100 ng/mL is recommended by the American Journal of Kidney Diseases 10

After IV iron administration, waiting 4-8 weeks before reassessing iron parameters is advised by the American Journal of Hematology 6
Monitoring hemoglobin response within 1-2 weeks of treatment is recommended by the American Journal of Hematology 6

Avoiding excessive iron supplementation and maintaining ferritin <500-800 ng/mL to prevent iron overload is crucial, as noted by Blood and the American Journal of Kidney Diseases 9, 10
The distinction between functional iron deficiency and inflammatory block is crucial for appropriate management, as emphasized by the American Journal of Kidney Diseases 2, 3